Senior Vice President, Translational Sciences
Marion Wittmann, Ph.D., has served as our Vice President of Translational Sciences since September 2020. Prior to her role as Vice President of Translational Sciences, Dr. Wittmann served as our Vice President of Biology & Toxicology from December 2016 to September 2020. Prior to joining us, Dr. Wittmann was the Director of Alzheimer’s research at Biogen Inc. from October 2014 to November 2016. Dr. Wittmann has over 18 years of experience in drug discovery and development with core expertise in translational biomarkers and small and large molecule drug discovery in CNS indications. Dr. Wittmann received a M.S. in biology and a Ph.D. in neurobiology from the Eberhard-Karls-University in Tuebingen, Germany.